Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Nawar Abdul Latif, MD, MPH

Nawar Abdul Latif, MD, MPH Physician

Instructor A of Obstetrics and Gynecology Instructor A of Obstetrics and Gynecology

Dr. Latif is employed by Penn Medicine.

About Dr. Nawar A. Latif

Dr. Latif specializes in gynecologic oncology. He serves as an instructor of obstetrics and gynecology and as a co-investigator of the Uterus Transplant for Uterine Factor Infertility (UNTIL) Trial.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gestational Trophoblastic Disease and Choriocarcinoma
  • Gynecologic Cancer
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Hysterectomy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vaginal Hysterectomy
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Amerihealth
  • NJ Medicare
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Baghdad University Medical School
Residency: University of Baghdad
Residency: Detroit General Hospital
Residency: Northwestern Memorial Hospital
Residency: Hospital of the University of Pennsylvania

Memberships

American Congress of Obstetricians and Gynecologists, National Society of Gynecologic Oncology, National

Hospital Affiliation

Dr. Latif is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Nasioudis D, Wilson E, Mastroyannis SA, Latif NA: Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors. Eur J Obstet Gynecol Reprod Bio 238 : 2019.

Nasioudis D, Ko EM, Haggerty AF, Giuntoli RL 2nd, Burger RA, Morgan MA, Latif NA: Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created? Gyncol Oncol report : 2019.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Is adjuvant chemotherapy associated with a survival benefit for patients with stage I mucinous ovarian carcinoma?" Oral presentation, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Does surgical approach influence the rate of positive peritoneal cytology and lymph-vascular invasion for patients with stage I uterine cancer? Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Clear cell carcinoma of the ovary is associated with unique characteristics and prognosis compared to high grade serous carcinoma. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Kanninen T, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Residual disease is associated with a worse prognosis in patients with advanced stage sex cord-stromal tumors. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Radical hysterectomy for the management of FIGO stage II type II uterine cancer; use and outcomes. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Minimally invasive staging for stage I type II uterine cancer: use and outcomes. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Type of treatment facility impacts survival of patients with ovarian clear cell carcinoma. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. : 2018.

Nasioudis D, Mastroyannis SA, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Trends in the surgical management of malignant ovarian germ-cell tumors. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Impact of complete gross resection on the survival of patients with advanced stage ovarian carcinosarcoma. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Mastroyannis SA, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Presence of lymph-vascular invasion is associated with a worse prognosis for patients with advanced stage malignant ovarian germ cell tumors. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Academic Contact Info

Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
3rd Floor West

Philadelphia, PA 19104
Patient appointments: 800-789-7366 (PENN)